Anish Patel

Anish brings a broad set of experience spanning Development, Medical Affairs, and Commercial.

Prior to co-founding Enliven, Anish served as the Head of Medical Affairs at AbbVie Stemcentrx, where he was responsible for building external collaborations and driving early oncology programs towards clinical proof-of-concept. Previously, Anish contributed to the buildout of commercial and medical affairs capabilities, at Pharmacyclics for Imbruvica® (ibrutinib), culminating in the company’s acquisition by AbbVie for $21B.

Anish has also held leadership roles at MedImmune/AstraZeneca and Berlex/Bayer.

Anish earned a Doctor of Pharmacy from the University of Michigan, Ann Arbor, and a Bachelor of Science in Microbiology and Chemistry from the University of Illinois.